FDA Archives - CFO

Early Analysis Shows Pfizer COVID-19 Vaccine 90% Effective

Risk & Compliance

Early Analysis Shows Pfizer COVID-19 Vaccine 90% Effective

The company said 50 million doses of its two-shot vaccine could be available globally by the end of 2020.

By Lauren Muskett | November 9, 2020

Akorn Files for Chapter 11 After Failed Takeover

Credit & Capital

Akorn Files for Chapter 11 After Failed Takeover

The generic drugmaker listed $10 billion of debt and $10 billion of assets.

By Lauren Muskett | May 21, 2020

SEC Charges Drug Firm with Reg FD Violations

Risk & Compliance

SEC Charges Drug Firm with Reg FD Violations

In calls and emails, TherapeuticsMD shared material, nonpublic information about a new drug's likelihood of FDA approval with sell-side analysts.

By Vincent Ryan | August 20, 2019

Big Health Care Companies Are Undervalued

Investor Relations

Big Health Care Companies Are Undervalued

McKesson and Walgreens are strong, healthy companies, despite recent downturns in their stock prices, a CEO in the investment field says.

By David McCann | July 1, 2019

Is Not Telling the ‘Whole Truth’ Securities Fraud?

Risk & Compliance

Is Not Telling the ‘Whole Truth’ Securities Fraud?

A jury verdict that held an ex-CFO liable for misleading investors makes clear that the SEC will take action against incomplete disclosures.

By Paul Hastings LLP and Nicolas Morgan and Brian Kaewert | November 27, 2018

Biotech CFO Accused of Misleading Investors

Risk & Compliance

Biotech CFO Accused of Misleading Investors

The ex-CFO of Aveo Pharmaceuticals and other top executives allegedly failed to disclose FDA concerns about an experimental cancer drug.

By Matthew Heller | March 30, 2016

Health Care: Things are Looking App

Health Care: Things are Looking App

Mobile health apps are becoming more capable and potentially rather useful.

By Economist Staff | March 14, 2016

Taxing Their Patience

Taxing Their Patience

The Affordable Care Act's medical-device tax and a proposed Internet sales tax could rile CFOs in 2014.

By Kathy Hoffelder | December 6, 2013

The Best Medicines

The Best Medicines

Merck invests billions in drug R&spamp;D every year, and it&spamp;rsquo;s up to CFO Peter Kellogg to ensure that the money is spent wisely.

By Edward Teach | March 21, 2013

Alternative Health Benefits: “Like Bringing Your Pet to Work”?

Human Capital & Careers

Alternative Health Benefits: “Like Bringing Your Pet to Work”?

Despite one manufacturer’s staunch insistence that its broad coverage of alternative medicine practices yields big benefits, skeptics abound.

By David McCann | October 31, 2012